North America Point-Of-Care Diagnostics Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Oct 2019
  • North America
  • 150 Pages
  • No of Tables: 30
  • No of Figures: 50

North America Point-Of-Care Diagnostics Market By Product (Glucose Monitoring Products, Cardio metabolic, Infectious Disease, Coagulation, Pregnancy and Fertility, Tumor/Cancer Marker, Urinalysis, Cholesterol, Hematology, Drugs-of-Abuse, Fecal Occult, Others), Platform (Lateral Flow Assays (Immunochromatography Tests), Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), Prescription (Prescription-Based Testing, OTC Testing), End User (Clinical Laboratories, Outpatient Healthcare & Ambulatory Care Settings, Hospitals/Critical Care Centers, Home Care, Research Laboratories, Others), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026

Market Analysis: North America Point-Of-Care Diagnostics Market

North America point-of-care diagnostics market is registering a substantial CAGR in the forecast period of 2019-2026. This growth in market value can be attributed to the increasing implementation of POC testing devices and home based diagnostic tests in home care.

Market Definition: North America Point-Of-Care Diagnostics Market

Point-Of-Care diagnostics are the methods used to detect infections early and rapidly. Such methods are highly sensitive, cost-effective and produce results within a limited timeframe. Such testing methods are used by physicians, schools, outpatients, home health and clinical labs. Point-of-care diagnostics are simple medical assessments that can be done on the bedside. In many situations, clarity was not attainable until technology developed not only to make the test practical at all, but also to conceal its ambiguity.

Market Drivers

  • Strong predominance of infectious disease, drives the market growth
  • Increasing usage of home-based POC devices, drives the market growth
  • Rising number of regulatory approvals for modern immunoassay techniques, driving the growth of market
  • Technological advances and new product releases, drives the market growth

Market Restraints

  • Pricing pressure due to repayment cuts and budget constraint, hampering the market growth
  • Time-consuming compliance policies substantially increase gestation period for product launches, which is expected to restrain the market growth
  • Product recalls, hampering the overall market growth

Segmentation: North America Point-Of-Care Diagnostics Market

By Product

  • Glucose Monitoring Products

    • Strips
    • Meters
    • Lancets & Lancing Device

  • Cardiometabolic

    • Cardiac Marker
    • Blood Gas/Electrolytes
    • HBA1C

  • Infectious Disease

    • Influenza
    • HIV
    • Hepatitis C
    • Sexually Transmitted Disease (STD)
    • Healthcare-Associated Infection (HAI)
    • Respiratory Infection
    • Tropical Disease
    • Other Infectious Disease

  • Coagulation

    • PT/INR
    • Activated Clotting Time (ACT/APTT)

  • Pregnancy and Fertility

    • Pregnancy test
    • Fertility test

  • Tumor/Cancer Marker
  • Urinalysis
  • Cholesterol
  • Hematology
  • Drugs-of-Abuse
  • Fecal Occult
  • Others

By Platform

  • Lateral Flow Assays (Immunochromatography tests)
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

By Prescription

  • Prescription-Based Testing
  • OTC Testing

By End User

  • Clinical Laboratories
  • Outpatient Healthcare & Ambulatory Care Settings
  • Hospitals/Critical Care Centers
  • Home Care
  • Research Laboratories
  • Others

By Country

  • U.S.
  • Canada
  • Mexico

Key Developments in the Market:

  • In February 2019, Abbott has launched a rapid influenza diagnostic test, BinaxNOW Influenza A & B Card 2. The reformulated experiment was given revocation status under the Clinical Laboratory Assessment Modifications of the U.S. Food and Drug Administration for use with Abbott's DIGIVAL test reader for fast influenza virus diagnosis. With this launch the company has expanded its product portfolio as well as increased its market share.
  • In July 2017, Quidel Corporation has entered into decisive agreements for the acquisition of Alere Triage Products, which involves toxicology products, Triage MeterPro cardiac and B-type Naturetic Peptide assays carried out by Beckman Coulter analyzers. Such goods are being disposed of in order to obtain the antitrust approvals needed for Abbott's pending takeover of Alere. With this acquisition company has expanded its product portfolio as well as increased its market share

Competitive Analysis:

North America point-of-care diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of point-of-care diagnostics market for North America.

Key Market Competitors:

Few of the major market competitors currently working in the North America point-of-care diagnostics market are Abbott, Danaher, BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Instrumentation Laboratory S.p.A. – Werfen, bioMérieux SA, Trividia Health, Inc., QIAGEN, Sekisui Diagnostics, Siemens Healthcare GmbH, Quidel Corporation, Spectral Medical Inc., Abaxis, Nova Biomedical, Trinity Biotech, Alfa Scientific Designs, Inc., ​PTS Diagnostics, Bio-Rad Laboratories, Inc., and Medica Corporation among others.

Research Methodology:  North America Point-Of-Care Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of North America point-of-care diagnostics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us